Bailey Jeffrey Allen

Insider profile

Performance

Overall performance
3.3

Performance over holding periods
3.3
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 43% 68% 82%
Transactions
6 83% Buy
34 71% Buy
47 69% Buy
Bailey Jeffrey Allen's trades of Aurinia Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-11-12 2024-11-11 S Sale
66,117 -47.2%
62.50
US$2,410,671
66,117 -47.2% 62.50 US$2,410,671
2020-12-16 2020-12-15 S Sale
3,491 -2.7%
302.66
US$2,486,875
3,491 -2.7% 302.66 US$2,486,875
2020-09-23 2020-09-23 B Purchase
53,967 +30.5%
431.77
US$4,540,636
53,967 +30.5% 431.77 US$4,540,636
2020-09-23 2020-09-23 B Purchase
710 +inf%
14.18
US$10,068
710 +inf% 14.18 US$10,068
2020-09-23 2020-09-23 B Purchase
570 +inf%
17.68
US$10,078
570 +inf% 17.68 US$10,078
2020-09-23 2020-09-22 B Purchase
580 +inf%
17.28
US$10,022
580 +inf% 17.28 US$10,022
2019-11-14 2019-11-12 B Purchase
19,894 +inf%
0.53
US$10,544
19,894 +inf% 0.53 US$10,544